SLV Health Blood Drive

Similar documents
Pandemic (H1N1) (August 14, h GMT; 12 h EST) Update on the Qualitative Indicators

Regional Update Pandemic (H1N1) 2009

PUBLIC HEALTH UPDATE

Pandemic (H1N1) (August 28, h GMT; 12 h EST) Update on the qualitative indicators

Regional Update Pandemic (H1N1) 2009

Investigating Disease Epidemics through Simulation with a focus on Chikungunya in the Americas

First, Last Name DOB: Maternal Risk Questionnaire (MRQ)

Zika virus transmission: ECDC adaptation of WHO's Zika virus country classification scheme 1

Regional Update Pandemic (H1N1) 2009 (March 15, h GMT; 12 h EST)

Regional Update Pandemic (H1N1) 2009 (January 19, h GMT; 12 h EST)

DR. CLAUDINA E. CAYETANO REGIONAL MENTAL ADVISOR Pan-American Health Organization/ World Health Organization

First, Last Name: DOB: F91148 Maternal Risk Questionnaire

Regional Update Pandemic (H1N1) 2009 (July 31, h GMT; 17 h EST) Update on the Qualitative Indicators Epidemiological Week 29 intensity

ZIKA VIRUS WHAT IS THE SITUATION IN SINGAPORE? 6 September 2016

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2

Annex 2 A. Regional profile: West Africa

countries do not have information available for this indicator.

מדינת ישראל. Tourist Visa Table

Regional Update Pandemic (H1N1) 2009 (December 1, h GMT; 12 h EST)

מדינת ישראל. Tourist Visa Table. Tourist visa exemption is applied to national and official passports only, and not to other travel documents.

Eligibility List 2018

Special Topic. The ten leading causes of death in countries of the Americas

Terms and Conditions. VISA Global Customer Assistance Services

CALLING ABROAD PRICES FOR EE SMALL BUSINESS PLANS

Regional Update Pandemic (H1N1) 2009 (July 19, h GMT; 12 h EST)

Donor Prescreening Questions

Country Length Discount Travel Period Anguilla All 20% off 08/24/11 12/15/11 Antigua All 20% off 08/24/11 12/15/11 Argentina All 20% off 08/24/11

Hepatitis B and C in the Spotlight: A public health response in the Americas. Key Messages

APPENDIX II - TABLE 2.3 ANTI-TOBACCO MASS MEDIA CAMPAIGNS

ANNEX 3: Country progress indicators

World Health organization/ International Society of Hypertension (WH0/ISH) risk prediction charts

OVERVIEW OF THE POLIO ERADICATION AND ENDGAME STRATEGIC PLAN AND THE topv TO bopv SWITCH

WORLD COUNCIL OF CREDIT UNIONS 2017 STATISTICAL REPORT

Regional Update Pandemic (H1N1) 2009 (July 6, h GMT; 12 h EST)

Figure 1: Case Distribution of Dengue Hemorrhagic Fever, in %, by subregion, *This includes cases of dengue with complications.

Zika Virus. Public Information Update/phone script. Date: March 28, 2016 Time: 11:00 a.m.

*This response is constantly evolving and recommendations in this presentation may change over time, please call your district epidemiologist or a

Epidemiology and Response Datapack

Analysis of Immunization Financing Indicators from the WHO-UNICEF Joint Reporting Form (JRF),

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved

THE CARE WE PROMISE FACTS AND FIGURES 2017

FIRST CONFIRMED CASE OF IMPORTED ZIKA VIRUS IN HOUSTON, TEXAS. Preventing Transmission

Main developments in past 24 hours

Donor Support for Contraceptives and Condoms for STI/HIV Prevention

Regional Update Pandemic (H1N1) 2009 (May 24, h GMT; 12 h EST)

ASSESSMENT OF IMPACTS OF AIR POLLUTION ON HEALTH

Hearing loss in persons 65 years and older based on WHO global estimates on prevalence of hearing loss

Tipping the dependency

World Health Organization Department of Communicable Disease Surveillance and Response

Supplementary appendix

ADMINISTRATIVE AND FINANCIAL MATTERS. Note by the Executive Secretary * CONTENTS. Explanatory notes Tables. 1. Core budget

Zika Outbreak: a PHEIC & Zika virus preparedness and response ac:vi:es in the African Region. Dr Zabulon Yo, & Dr Anthony Stewart

ZIKA VIRUS MICROCEPHALY AND GUILLAIN-BARRÉ SYNDROME

HIBA ABDALRAHIM Capsca Focal Point Public Health Authority

FRAMEWORK CONVENTION ALLIANCE BUILDING SUPPORT FOR TOBACCO CONTROL. Smoke-free. International Status Report

Maternal Deaths Disproportionately High in Developing Countries

3.5 Consumption Annual Prevalence Opiates

Doral Police Department - Office of Emergency Management. Action Plan Zika Virus Prevention, Preparedness and Outreach Date: Feb.

Hepatitis B and C Basics

WHO report highlights violence against women as a global health problem of epidemic proportions

Challenges and Opportunities to Optimizing the HIV Care Continuum Can We Test and Treat Enough People to Make a Seismic Difference by 2030?

Regional Update Influenza (August 16, h GMT; 12 h EST)

Malnutrition prevalences by country and year, from survey data and interpolated for reference years (1990, 1995, 2000)

Calls from home residential tariffs

Outcomes of the Global Consultation Interim diagnostic algorithms and Operational considerations

GLOBAL RepORt UNAIDS RepoRt on the global AIDS epidemic

TOBACCO USE PREVALENCE APPENDIX II: The following definitions are used in Table 2.1 and Table 2.3:

Epidemiological Estimates for Haemoglobin Disorders: WHO South East Asian Region by Country

50th DIRECTING COUNCIL 62nd SESSION OF THE REGIONAL COMMITTEE

Everything you ever wanted to know about Zika Virus Disease

Acute Public Health Events Assessed by WHO Regional Offices for Africa, the Americas, and Europe under the International Health Regulations (2005)

Epidemiological Update Dengue

Epidemiological Alerts and Updates. Annual Report

Human Papillomavirus and Related Cancers

Various interventions for controlling sexually transmitted infections have proven effective, including the syndromic

Tobacco: World Markets and Trade

Pacific Telecom Inc. (PTI) Message Telecommunications Service Table of General Rates

Why Invest in Nutrition?

AGaRT The Advisory Group on increasing access to Radiotherapy Technology in low and middle income countries

JOINT TB AND HIV PROGRAMMING

Epidemiological Estimates for Haemoglobin Disorders: The World by WHO Region

Florida Arbovirus Surveillance Week 38: September 16-22, 2012

Florida Arbovirus Surveillance Week 39: September 23-29, 2012

Florida Arbovirus Surveillance Week 36: September 2-8, 2012

Diabetes Advocacy Experience

Scaling Up Antiretroviral Treatment Sustainably

Florida Arbovirus Surveillance Week 37: September 9-15, 2012

Florida Arbovirus Surveillance Week 42: October 14-20, 2012

1. Consent for Treatment This form must be completed in order to receive healthcare services in the campus clinic.

Welcome All. Western Australia Oncology Menopause Endometriosis New Mothers

Seizures of ATS (excluding ecstasy ), 2010

Cherokee Trail High School Blood Drive. Please help us to save lives! February 14th. 8:00 to 9:40 am & 11:00 am to 1:30 pm Upper Lecture Center

Practice Current: "When Do You Stop AEDS?"

ACCESS 7. TOWARDS UNIVERSAL ACCESS: THE WAY FORWARD

Malaria. You are part of it! Healthier, fitter, safer.

General Description. Significance

Financing malaria control

Adding It Up: Investing in Contraception and Maternal and Newborn Health, 2017 Supplementary Tables

Transcription:

SLV Health Blood Drive Friday, October 21 st From 10:30 a.m. until 2:30 p.m. Held at the SLV health Conference Center at 1921 Main To schedule your appointment, please contact Jho Cura at (719) 587-1226 or jhoanna.cura@slvrmc.org OR Mary Rice at (719) 587-1225 or mary.rice@slvrmc.org Walk-in s are welcome and will be worked in around scheduled appointments. Please eat a hearty meal and drink lots of water before you donate blood! Did you know that 30 percent of people don't show up to their blood donation appointment? We are counting on you to help us prevent shortages in the blood supply by honoring your appointment to give blood. Bonfils Blood Center 717 Yosemite Street, Denver, CO 80230 Contact Us 303.341.4000, opt. 3 800.365.0006, opt. 3

Donor Prescreening Questions CDO-384-PRD REV 19 Please read the following in its entirety to help guarantee your safety and the safety of the community blood supply and to help ensure you have a positive donation experience. Bonfils recommends that prior to your donation you eat within 2 hours and hydrate for 24-48 hours. If you would like something to eat or drink before your donation please help yourself to the items in the canteen area. Donors are commonly deferred for the following questions. Bonfils asks these prescreening questions so donors do not spend time answering our full questionnaire only to find they are ineligible for a common reason. Even if you answer no to all of these prescreening questions, you may be ineligible to donate based on the answers given during the full questionnaire and interview process completed just prior to the actual donation. If you answer yes to any of these questions on the day you present to donate, you will NOT be eligible to donate at that time. If you have any questions related to travel or your eligibility to donate as a whole contact Bonfils Donor Relations department at 303.363.2202 or 800.365.0006, opt. 1 or ask a Bonfils staff member at the time of your donation. HEALTH STATUS AND AGE 1. Do you weigh less than 110 pounds or more than 350 pounds? 2. Are you 15 years or younger? 3. Are you ill or not feeling well today? 4. Have you ever been diagnosed with lymphoma and/or leukemia? MEDICATIONS 5. Are you taking antibiotics today for an active infection? 6. Have you taken Accutane, Proscar or Propecia in the last month? 7. Have you taken Coumadin/Warfarin in the last 7 days? TATTOOS AND PIERCINGS 8. Have you received a tattoo that was not performed in a doctor s office in the last 12 months?* 9. Have you received an ear or body piercing that was not performed with single-use equipment in the last 12 months?* TRAVEL AND RESIDENCE ABROAD 10. From 1980 through 1990 were you in Belgium, Germany, the Netherlands or Holland as a member of the U.S. military, a civilian military employee or a dependent of a member of the U.S. military for 6 months or more?* 11. From 1980 through 1996 were you in Spain, Portugal, Turkey, Italy, Sicily or Greece as a member of the U.S. military, a civilian military employee or a dependent of a member of the U.S. military for 6 months or more?* 12. From 1980 to present have you spent time that adds up to 5 years or more in Europe?* 13. In the past 12 months have you spent more than 24 hours in (traveled to) any individual location outside of the U.S. or Canada?* a. If yes, did you travel to any of the countries or cities listed as a malarial risk area on the table on the back of this page? There are many ways to save lives with Bonfils. You can also help through Bonfils marrow program and volunteer opportunities. *Additionally, if you are deferred for these categories, you may still be eligible for research donations. Visit bonfils.org to learn more. PG 1 OF 2 Please call Bonfils Donor Relations department at 303.363.2202 or 800.365.0006, opt. 1 for complete information on donor eligibility.

The table below is referenced in prescreening question 13a. Like the prescreening questions on this document that reference common deferrals but not all deferrals, this table includes common malarial risk areas but it is not an all-inclusive list. AFGHANISTAN CAMBODIA HAITI NICARAGUA AFRICA Angola Botswana Burundi Cameroon Central African Republic Chad Congo Ethiopia Gabon Gambia Ghana Ivory Coast Kenya Liberia Mozambique Niger Nigeria Rwanda Senegal Sierra Leone Somalia Sudan Tanzania Uganda Zaire Zambia Zimbabwe CHINA Dali Banna Chuxiong City Dian Lake Jade Dragon Snow Mountain Jinghong Kunming Lijiang Nansha New Yuanyang Old Yunanyang Panzhihua Shangri-la Shilin Stone Forest Tiger Leaping Gorge Xinje Yunnan COLOMBIA Any area outside Bogota or Cartegena DOMINICAN REPUBLIC Any area outside Santiago or Santo Domingo HONDURAS Any area outside San Pedro Sula or Tegucigalpa (including the Bay Islands) INDIA INDONESIA IRAN MALAYSIA MEXICO Chihuahua City Copper Canyon Durango El Fuerte Hidalgo del Parral Los Mochis Mazatlan Nuevo Mazatlan Nuevo Vallarta Punta Mita Sayulita PANAMA Any area east of the Panama Canal including the region of Colon SOUTH KOREA Any area north of Seoul, including the Demilitarized Zone (DMZ) VIETNAM Please call Bonfils Donor Relations department at 303.363.2202 or 800.365.0006, opt. 1 for complete information on donor eligibility. PG 2 OF 2

Zika Virus: Notice to Travelers & Educational Material These are the areas where Zika is present. Do NOT donate blood for 28 days after returning from any of these places. UNITED STATES Florida: Miami-Dade & Palm Beach Counties CENTRAL AMERICA Belize Costa Rica El Salvador Guatemala Honduras Nicaragua Panama SOUTH AMERICA Argentina Bolivia Brazil Chile Colombia Ecuador Falkland, South Georgia & South Sandwich Islands (UK) French Guiana Guyana Paraguay Peru Suriname Uruguay Venezuela ATLANTIC & PACIFIC ISLANDS American Samoa Cape Verde Federated States of Micronesia Fiji Marshall Islands New Caledonia Papua New Guinea Samoa Tonga MEXICO All Locations SINGAPORE All Locations CARIBBEAN Anguilla (UK) Antigua & Barbuda Aruba (Netherlands) Bahamas Barbados Bermuda Bonaire (Netherlands) British Virgin Islands (UK) Cayman Islands (UK) Cuba Curaçao (Netherlands) Dominica Dominican Republic Grenada Guadeloupe (France) Haiti Jamaica Martinique (France) Montserrat (UK) Puerto Rico (US) Saba (Netherlands) Saint Barthélemy (France Saint Kitts & Nevis Saint Lucia Saint Martin (France) Saint Vincent & the Grenadines Sint Eustatius (Netherlands) Sint Maarten (Netherlands) Trinidad & Tobago Turks & Caicos Islands (UK) United States Virgin Islands (US) Please see reverse for important additional information August 31, 2016 Page 1 of 2 CDO-VC-38 rev 11

Zika Virus: Notice to Travelers & Educational Material The United States, Mexico, the Caribbean, Central and South America, Singapore, American Samoa, Samoa, Tonga, and Cape Verde Islands What is Zika? Zika is a virus carried by mosquitos. Zika virus causes symptoms of: Fever Rash Joint or muscle pain Eye pain or redness Headache How is Zika transmitted? Through bite of an infected mosquito From a pregnant mother to her baby Through sexual contact Possibly by blood transfusion You should NOT donate today if in the PAST 4 WEEKS: You have been in an area where Zika is present (see the current list on other side) You had symptoms from a known case of Zika You have had two or more symptoms listed above following recent travel (within 2 weeks) to an area where Zika is present (see list) You have had sexual contact with a man who: Had a known case of Zika in the past 3 months Has been in an area where Zika is present in the past 3 months (see list) Important Post Donation Information: Certain illnesses can be transmitted to patients through blood transfusion from an infected donor. These illnesses include those contracted while traveling abroad (such as Zika, dengue, chikungunya, and malaria) or domestically (such as West Nile virus and influenza). Although you feel well and healthy at the time of your donation, please call us immediately at the phone number beside our blood center s name below if you develop two or more of the following symptoms within 14 days of your blood donation. Fever Rash Muscle or joint Eye pain or Headache pain redness By notifying us as soon as possible after developing any of these symptoms you may prevent the blood you donated today from being transfused and possibly infecting a patient. NOTE: If you recall being potentially at risk for Zika exposure (refer to criteria above) in the past 4 weeks, please call us. Although you are feeling well, you could be infected with Zika Bonfils Blood Center www.bonfils.org 303-363-2202 August 31, 2016 Page 2 of 2 CDO-VC-38 rev 11